Get the Stockscreener App
115.90
2.69%
-3.21
After Hours:
115.90
Neurocrine Biosciences Inc Stock (NBIX) Latest News
Neurocrine Biosciences Sets March Schedule for Crucial Investor PresentationsWhat's Coming? - StockTitan
Endometriosis Pipeline Drugs Analysis Report: FDA Approvals, - openPR
Neurocrine Biosciences authorizes $500M share repurchase program - MSN
Is Neurocrine Biosciences (NBIX) One of the Best Fast Growth Stock to Buy Right Now? - Insider Monkey
Shareholders Can Be Confident That Neurocrine Biosciences' (NASDAQ:NBIX) Earnings Are High Quality - Simply Wall St
Neurocrine Biosciences' (NASDAQ:NBIX) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
DSM Capital Partners LLC Has $127.30 Million Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - MarketBeat
Neurocrine Biosciences, Inc. authorizes a Buyback Plan. -February 20, 2025 - Marketscreener.com
Assessing Neurocrine Biosciences: Insights From 15 Financial Analysts - Benzinga
Huntington's Disease Market Growth to Accelerate in Forecast - openPR
Neurocrine Biosciences sets $500M share buyback plan By Investing.com - Investing.com South Africa
Neurocrine Biosciences sets $500M share buyback plan - Investing.com India
Neurocrine Biosciences Approves $500 Million Share Repurchase Program -February 21, 2025 at 08:19 am EST - Marketscreener.com
Neurocrine Board Authorizes Share Repurchase ProgramQuick Facts - Nasdaq
Neurocrine Biosciences (NBIX) Announces $500M Share Buyback - StreetInsider.com
Can Neurocrine's New $500M Buyback Signal Even Stronger Growth Ahead? - StockTitan
Leerink Partnrs Issues Optimistic Outlook for NBIX Earnings - MarketBeat
Rice Hall James & Associates LLC Sells 6,785 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - MarketBeat
Neurocrine Biosciences (NASDAQ:NBIX) Downgraded to Buy Rating by StockNews.com - MarketBeat
AlphaCentric Advisors LLC Sells 18,816 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - MarketBeat
Neurocrine Biosciences Board Of Directors Authorizes $500 Million Share Repurchase Program - Marketscreener.com
Leerink Partnrs Has Pessimistic View of NBIX Q3 Earnings - MarketBeat
Ieq Capital LLC Increases Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - MarketBeat
Van ECK Associates Corp Buys 9,824 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - MarketBeat
New York State Teachers Retirement System Cuts Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - MarketBeat
Vontobel Holding Ltd. Has $1.15 Million Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - MarketBeat
Matt Abernethy Sells 2,558 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock - MarketBeat
Neurocrine (NBIX): Among Top Insider Stock Buys And Sells In January - Insider Monkey
Neurocrine Biosciences chief legal officer sells $107,727 in stock - MSN
Neurocrine Biosciences' chief corporate affairs officer sells shares worth $208,387 - MSN
Neurocrine Biosciences CFO Matt Abernethy sells $115,908 in stock - MSN
Neurocrine Biosciences' SWOT analysis: navigating growth amid market shifts By Investing.com - Investing.com Nigeria
Neurocrine Biosciences' SWOT analysis: navigating growth amid market shifts - Investing.com
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Sees Large Drop in Short Interest - MarketBeat
Stanley Laman Group Ltd. Increases Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - MarketBeat
Neurocrine Biosciences CHRO sells shares worth $181,129 - MSN
Insider Selling: Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Director Sells 5,844 Shares of Stock - MarketBeat
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Position Trimmed by Allspring Global Investments Holdings LLC - MarketBeat
Julie Cooke Sells 1,551 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock - MarketBeat
Neurocrine Biosciences chief legal officer sells $254,991 in stock - MSN
Stifel maintains Neurocrine Bio stock target, positive on Takeda deal - MSN
Savant Capital LLC Purchases Shares of 16,543 Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - MarketBeat
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) CEO Kyle Gano Sells 980 Shares - MarketBeat
Insider Selling: Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Director Sells 2,274 Shares of Stock - MarketBeat
Neurocrine Biosciences chief scientific officer sells $336,238 in stock - MSN
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock Position Cut by Fiera Capital Corp - MarketBeat
Neurocrine Biosciences executive sells shares totaling $258,263 - MSN
Neurocrine Biosciences chief commercial officer sells $251,426 in stock - MSN
Neurocrine Biosciences director Sherwin sells $1.6m in stock - MSN
Neurocrine Biosciences CEO sells shares for $298,907 By Investing.com - Investing.com Australia
Neurocrine Biosciences chief corporate affairs officer sells $82,820 in stock - MSN
Neurocrine Biosciences chief commercial officer sells $115,940 in stock - MSN
Neurocrine Biosciences executive sells shares worth $82,792 - MSN
0.01%
1.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):